| Scrip Code | 532504 |
|---|---|
| NSE Symbol | NAVINFLUOR |
| MSEI Symbol | NOTLISTED |
| ISIN | INE048G01026 |
| Name of company | Navin Fluorine International Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 09-02-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 23-12-2025 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Third quarter |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | Chemicals |
| Start date and time of board meeting | 09-02-2026 13:45:00 |
| End date and time of board meeting | 09-02-2026 16:00:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? | Yes |
| No. of times funds raised during the quarter | 1 |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? | No |
| - | |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| 1 | Income | ||
| Revenue from operations | 57,001.00 | 1,67,533.00 | |
| Other income | 1,987.00 | 6,819.00 | |
| Total income | 58,988.00 | 1,74,352.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 24,775.00 | 73,226.00 |
| (b) | Purchases of stock-in-trade | 0.00 | 0.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 1,178.00 | 1,779.00 |
| (d) | Employee benefit expense | 5,460.00 | 16,182.00 |
| (e) | Finance costs | 216.00 | 508.00 |
| (f) | Depreciation, depletion and amortisation expense | 1,914.00 | 5,770.00 |
| (f) | Other Expenses | ||
| 1 | Other Expenses | 9,502.00 | 28,346.00 |
| Total other expenses | 9,502.00 | 28,346.00 | |
| Total expenses | 43,045.00 | 1,25,811.00 | |
| 3 | Total profit before exceptional items and tax | 15,943.00 | 48,541.00 |
| 4 | Exceptional items | (1,884.00) | (1,884.00) |
| 5 | Total profit before tax | 14,059.00 | 46,657.00 |
| 6 | Tax expense | ||
| 7 | Current tax | 3,470.00 | 10,888.00 |
| 8 | Deferred tax | 2.00 | 505.00 |
| 9 | Total tax expenses | 3,472.00 | 11,393.00 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 10,587.00 | 35,264.00 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 10,587.00 | 35,264.00 |
| 17 | Other comprehensive income net of taxes | 78.00 | (157.00) |
| 18 | Total Comprehensive Income for the period | 10,665.00 | 35,107.00 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | |||
| Total profit or loss, attributable to non-controlling interests | |||
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | |||
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | |||
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 1,025.00 | 1,025.00 | |
| Face value of equity share capital | 2 | 2 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 20.66 | 69.65 | |
| Diluted earnings (loss) per share from continuing operations | 20.63 | 69.55 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 20.66 | 69.65 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 20.63 | 69.55 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | 1.The results of the quarter and nine months ended 31st December, 2025 were reviewed by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on 9th February, 2026. They have been subjected to limited review by the statutory auditors. 2.During the quarter ended 31st December, 2025 the Company paid an interim dividend of Rs. 6.50 per share (325%) on 5,12,39,124 equity shares of nominal value of Rs. 2/- each aggregating to Rs. 33.31 crores, for the financial year 2025-26. 3.During the quarter ended 30th September, 2025, the Fund raising committee at its meeting held on 11th July, 2025 has approved the allotment of 16,02,564 Equity Shares of Rs. 2/- each through Qualified Institutional Placement (QIP) under the provisions of Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and section 42 and 62 of the Companies Act, 2013, including the rules made thereunder as amended, to the eligible Qualified Institutional Buyers, at the issue price of Rs. 4,680.00 per Equity Share (including a premium of 4,678.00 per Equity Share), aggregating to approximately Rs. 750 crores. Expenses incurred in relation to QIP have been adjusted from Securities Premium Account. The funds raised by the Company pursuant to QIP have been fully utilized in accordance with the 'Use of Proceeds' mentioned in the placement document of QIP. 4.Pursuant to the notification issued by the Ministry of Labour and Employment, multiple existing labour legislations have been consolidated into a unified framework comprising four Labour Codes, collectively referred to as the ' New Labour Codes ' which became effective from 21st November, 2025. The Company has reassessed its employee benefit obligations in accordance with the revised definition of wages. Accordingly, an estimated incremental liability on employee benefit amounting to Rs. 18.84 crores has been recognized as an Exceptional item during the quarter and nine months ended 31st December, 2025. The Company is monitoring updates on the rules and clarifications by State and / or Central Government authorities in relation to the New Labour Codes and impact of those will be evaluated and accounted for in the period in which they are notified. 5.The Company operates only in one Business Segment i.e., `Chemical Business` which constitutes single reportable segment in accordance with the requirements of Ind AS 108, ‘Operating Segments’. |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-10-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 31-12-2025 | 31-12-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Standalone | Standalone | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement loss of the define benefit obligation | 104.00 | (210.00) |
| Total Amount of items that will not be reclassified to profit and loss | 104.00 | (210.00) | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 26.00 | (53.00) |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | 78.00 | (157.00) |
| Mode of Fund Raising | QIP |
|---|---|
| Description of mode of fund raising (Applicable in case of others is selected) | |
| Date of Raising Funds | 11-07-2025 |
| Amount Raised | 75,000.00 |
| Report filed for Quarter ended | 31-12-2025 |
| Monitoring Agency | Applicable |
| Monitoring Agency Name, if applicable | CARE RATINGS LIMITED |
| Is there a Deviation / Variation in use of funds raised | No |
| If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders | |
| If Yes, Date of shareholder Approval | |
| Explanation for the Deviation / Variation | NOT APPLICABLE |
| Comments of the Audit Committee after review | NIL |
| Comments of the auditors, if any | NIL |
| Sr. | Original Object | Modified Object, if any | Original Allocation | Modified allocation, if any | Funds Utilised | Amount of Deviation/Variation for the quarter according to applicable object | Remarks if any |
| 1 | Repayment / pre-payment, in full or in part, of certain outstanding borrowings availed by our Company and/or its Subsidiary i.e. Navin Fluorine Advance Sciences Ltd (NFASL | Not Applicable | 56,250.00 | 0.00 | 56,250.00 | 0.00 | Utilised in Q2 - fy 2025-2026 Rs.415.43 cr. Utilised in Q3 - fy 2025-2026 Rs.147.07 cr. Approximately Rs 750 crores has been raised in Q2 FY 2025-2026 |
| 2 | General corporate purposes | Not Applicable | 16,750.00 | 0.00 | 17,075.00 | 0.00 | - |
| 3 | Issue related expenses | Not Applicable | 2,000.00 | 0.00 | 1,675.00 | 0.00 | There was no utilisation of the issue proceeds for this object in Q3FY26 |
| Name of signatory | ANISH GANATRA |
| Designation of person | Chief Financial Officer |
| Place | MUMBAI |
| Date | 09-02-2026 |